AC-P19M discovered in this study is a novel multi-target ACP that not only directly destroys cancer cells but also induces apoptosis, inhibits EMT, and inhibits angiogenesis, and may be expected to exhibit synergistic effects when combined with other methods. Here, ASAH1 is linked to cancer.